Lincoln Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Lincoln Pharmaceuticals has a total shareholder equity of ₹5.5B and total debt of ₹9.0M, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are ₹6.6B and ₹1.2B respectively. Lincoln Pharmaceuticals's EBIT is ₹883.2M making its interest coverage ratio -19.9. It has cash and short-term investments of ₹1.7B.
Key information
0.2%
Debt to equity ratio
₹8.97m
Debt
Interest coverage ratio | -19.9x |
Cash | ₹1.71b |
Equity | ₹5.46b |
Total liabilities | ₹1.17b |
Total assets | ₹6.63b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 531633's short term assets (₹4.4B) exceed its short term liabilities (₹1.0B).
Long Term Liabilities: 531633's short term assets (₹4.4B) exceed its long term liabilities (₹141.0M).
Debt to Equity History and Analysis
Debt Level: 531633 has more cash than its total debt.
Reducing Debt: 531633's debt to equity ratio has reduced from 14.5% to 0.2% over the past 5 years.
Debt Coverage: 531633's debt is well covered by operating cash flow (8899.6%).
Interest Coverage: 531633 earns more interest than it pays, so coverage of interest payments is not a concern.